Echocardiographic changes in elderly patients after blood transfusion
Official title: Variation of Echocardiographic Parameters After Red Blood Cell Transfusion in Emergency Department Anemic Patients
Run by Centre Hospitalier Universitaire de Nīmes · NCT06060639 · Data updated 2026-11-12
This study is testing how blood transfusions affect heart function in elderly patients by checking their heart images before and after the transfusion.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 116 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de Nīmes Academic / other |
| Locations | 1 site (Nîmes, Gard) |
| Status | Recruiting |
| Started | November 9, 2023 |
| Main results expected | May 30, 2027 |
| Study ends | May 30, 2027 |
| Registry record updated | December 30, 2025 |
| Trial ID | NCT06060639 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are elderly patients in the emergency department who require a red blood cell transfusion.
✕Probably not a fit
Patients who have received a transfusion within the last hour or those with significant fluid overload may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study aims to assess the variations in echocardiographic parameters in elderly patients receiving red blood cell transfusions in the emergency department. Participants will undergo transthoracic echocardiography before, immediately after, and 15 minutes post-transfusion to evaluate any changes in their heart function. The study seeks to identify which echocardiographic parameter is most affected by the transfusion. By understanding these variations, the study hopes to improve patient management in emergency settings.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of cardiac responses to blood transfusions in anemic elderly patients, leading to better clinical practices.
How similar studies have gone: While there may be limited studies specifically addressing echocardiographic changes post-transfusion in elderly patients, similar approaches have shown promise in understanding cardiac responses in various populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patient needing red blood cell transfusion * consent * social protection Exclusion Criteria: * fluid filing over 500 mL of crystalloids * transfusion in the last hour
Where it's running
-
CHU de Nîmes
Nîmes, Gard, France Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
DISC-0974-201 for adults with IBD-related anemia
This Phase 2 trial will test whether DISC-0974-201 helps adults with inflammatory bowel disease who have anemia driven by inflammation.
-
National registry for people with myelofibrosis and anemia in Germany.
This project will collect health, treatment, and quality-of-life information from people in Germany with primary or secondary myelofibrosis and anemia to see how their care and symptoms change over time.
-
Evaluating DISC-0974 for treating anemia in myelofibrosis patients
This study tests if a new treatment called DISC-0974 can help people with myelofibrosis who have anemia feel better and improve their condition.
-
Core muscle function and balance in people with leg amputations
This study tests how leg amputation affects core muscles and balance by comparing muscle thickness on the amputated side, the intact side, and healthy people using ultrasound.
-
Iron status at ICU discharge in adults with anemia after critical illness
We are testing whether iron deficiency is common at ICU discharge and whether it relates to how well patients recover after leaving the ICU.
-
Luspatercept for anemia due to chronic kidney disease
This study tests whether luspatercept can raise hemoglobin levels in people with anemia caused by CKD and whether it is safe.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.